Target intelligence / Profile preview

Xanthomonas

Molecular classification
Bacteria (NCBI, 2024), Gram-negative bacteria (Wikipedia, 2024), Proteobacteria (NCBI, 2024), Other (Bacterial Genus)
01

Overview

Xanthomonas is a genus of Gram-negative, rod-shaped Proteobacteria that serves as a major model for studying plant-pathogen interactions and is of significant interest in agricultural biotechnology (Wikipedia, 2024). These bacteria are characterized by their use of a Type III secretion system to deliver Transcription Activator-Like (TAL) effectors into host cells, which act as transcription factors to hijack host metabolism (Boch & Bonas, 2010). While Xanthomonas itself is not a human therapeutic target, its proteins—specifically TAL effectors—have been repurposed as TALENs for precision genome engineering in human therapeutics and research (Nature, 2011). In an agricultural context, Xanthomonas species cause devastating diseases such as rice bacterial blight and citrus canker, leading to substantial economic losses (Ryan et al., 2011). The genus is also the primary source of xanthan gum, an industrially vital polysaccharide used as a stabilizer in pharmaceutical formulations (Leyns et al., 1984). Current control strategies rely on bactericides and antibiotics like streptomycin, though the rise of resistance has spurred research into novel antimicrobial peptides and CRISPR-based control mechanisms (PubMed, 2021).

Other names
XanthomonadsXanthomonas species
02

Mechanism of action

Inhibition of bacterial protein synthesis via 30S ribosomal subunit binding (aminoglycosides/tetracyclines) or non-specific protein denaturation and enzyme disruption by copper ions (PubMed, 2021; ScienceDirect, 2022).

03

Biological functions

Plant pathogenesis (Ryan et al., 2011)Biofilm formation (PubMed, 2021)Extracellular polysaccharide production (Leyns et al., 1984)Type III secretion (Boch & Bonas, 2010)Motility (Wikipedia, 2024)
04

Disease associations

Infection (Wikipedia, 2024)Bacterial blight (Ryan et al., 2011)Citrus canker (Boch & Bonas, 2010)Black rot (APS, 2023)
05

Safety considerations

Development of multi-drug resistance in agricultural settings (PubMed, 2021)Environmental toxicity and soil accumulation of copper-based treatments (ScienceDirect, 2022)Phytotoxicity to host plants (APS, 2023)Impact on non-target soil microbiota (ScienceDirect, 2022)
06

Interacting drugs

Streptomycin (PubMed, 2021)

4 more in the full profile.

07

Biomarkers

Transcription Activator-Like (TAL) effectors (Boch & Bonas, 2010)Xanthan gum (Leyns et al., 1984)16S rRNA sequences (NCBI, 2024)Xanthomonadin pigment (NCBI, 2023)

Beyond the preview

Go deeper on Xanthomonas.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xanthomonas.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call